These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14872100)

  • 21. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
    Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
    Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
    Zandman-Goddard G; Blank M; Langevitz P; Slutsky L; Pras M; Levy Y; Shovman O; Witte T; Doria A; Rovensky J; Shoenfeld Y
    Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease.
    Schett G; Dumortier H; Hoefler E; Muller S; Steiner G
    Ann Rheum Dis; 2009 May; 68(5):729-35. PubMed ID: 18495733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antichromatin antibodies can be useful as a diagnostic tool and disease activity marker of systemic lupus erythematosus in Koreans.
    Kim HA; Jeon JY; Choi GS; Sung JM; Kim MJ; Yun JM; Suh CH
    Clin Immunol; 2008 Aug; 128(2):277-83. PubMed ID: 18504161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus.
    Soep JB; Mietus-Snyder M; Malloy MJ; Witztum JL; von Scheven E
    Arthritis Rheum; 2004 Jun; 51(3):451-7. PubMed ID: 15188333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
    Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
    Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus.
    Garrido-Sánchez L; Cardona F; García-Fuentes E; Rojo-Martínez G; Gómez-Zumaquero JM; Picón MJ; Soriguer F; Tinahones FJ
    Eur J Clin Invest; 2008 Sep; 38(9):615-21. PubMed ID: 18837736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negligible synergistic effect of beta2-glycoprotein I on the reactivity of antioxidized low-density lipoprotein antibody to oxidized low-density lipoprotein.
    Matsuda J; Gotoh M; Kawasugi K; Gohchi K; Tsukamoto M; Saitoh N
    Am J Hematol; 1996 Jun; 52(2):114-6. PubMed ID: 8638631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosus.
    Seelen MA; van der Bijl EA; Trouw LA; Zuiverloon TC; Munoz JR; Fallaux-van den Houten FC; Schlagwein N; Daha MR; Huizinga TW; Roos A
    Rheumatology (Oxford); 2005 Jan; 44(1):111-9. PubMed ID: 15479757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between clinical activity and serological markers in a wide cohort of patients with systemic lupus erythematosus: an eight-year prospective study.
    Villegas-Zambrano N; Martínez-Taboada VM; Bolívar A; San Martín M; Alvarez L; Marín MJ; López-Hoyos M
    Ann N Y Acad Sci; 2009 Sep; 1173():60-6. PubMed ID: 19758133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological studies of reactive oxygen species damaged catalase in patients with systemic lupus erythematosus: correlation with disease activity index.
    Al-Shobaili HA; Al Robaee AA; Alzolibani AA; Rasheed Z
    Immunol Invest; 2013; 42(3):191-203. PubMed ID: 23461612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE.
    Ye Y; Wu T; Zhang T; Han J; Habazi D; Saxena R; Mohan C
    Clin Immunol; 2019 Aug; 205():43-48. PubMed ID: 31075396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-oxidized LDL antibody levels are reduced in women with hypertension.
    Garrido-Sánchez L; García-Fuentes E; Cardona F; Rojo-Martínez G; Soriguer F; Tinahones FJ
    Eur J Clin Invest; 2009 Sep; 39(9):800-6. PubMed ID: 19674079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
    Haddouk S; Marzouk S; Jallouli M; Fourati H; Frigui M; Hmida YB; Koubaa F; Sellami W; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
    Rheumatology (Oxford); 2009 Aug; 48(8):953-7. PubMed ID: 19502474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oxidized low-density lipoprotein antibodies in systemic lupus erythematosus: their connection with phospholipid antibodies].
    Nasonov EL; Popkova TV; Efremov EE; Reshetniak TM; Kameneva AM; Aleksandrova EN; Fomicheva OA; Alekberova ZS
    Klin Med (Mosk); 1997; 75(9):49-52. PubMed ID: 9432544
    [No Abstract]   [Full Text] [Related]  

  • 40. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
    Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.